imipramine has been researched along with Carcinoma, Squamous Cell in 5 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral squamous cell carcinoma (OSCC) has limited treatment options." | 1.91 | Imipramine Suppresses Tumor Growth and Induces Apoptosis in Oral Squamous Cell Carcinoma: Targeting Multiple Processes and Signaling Pathways. ( Chang, PL; Chen, YT; Hsiao, HC; Hsieh, LL; Hsu, FT; Hsu, LC; Lin, CN; Lin, KH; Tu, HF; Wang, HY, 2023) |
| "Imipramine blue (IB) is a newly identified anti-invasive compound that effectively inhibits glioma invasion." | 1.43 | Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation. ( Arbiser, JL; Hsu, WH; Su, YH; Wang, CC; Yang, MH; Yang, WH, 2016) |
| "Imipramine binding sites were absent." | 1.27 | Alterations of beta-adrenergic, muscarinic cholinergic receptors and imipramine binding sites in human lung tumors. ( Lange, F; Lange, J; Morin, D; Tillement, JP; Zini, R, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, LC | 1 |
| Lin, CN | 1 |
| Hsu, FT | 1 |
| Chen, YT | 1 |
| Chang, PL | 1 |
| Hsieh, LL | 1 |
| Wang, HY | 1 |
| Lin, KH | 1 |
| Hsiao, HC | 1 |
| Tu, HF | 1 |
| Yang, WH | 1 |
| Su, YH | 1 |
| Hsu, WH | 1 |
| Wang, CC | 1 |
| Arbiser, JL | 1 |
| Yang, MH | 1 |
| Molnár, J | 1 |
| Mucsi, I | 1 |
| Kása, P | 1 |
| Orlandi, PA | 1 |
| Fishman, PH | 1 |
| Morin, D | 1 |
| Zini, R | 1 |
| Lange, F | 1 |
| Lange, J | 1 |
| Tillement, JP | 1 |
5 other studies available for imipramine and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Imipramine Suppresses Tumor Growth and Induces Apoptosis in Oral Squamous Cell Carcinoma: Targeting Multiple Processes and Signaling Pathways.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Disease Models, Animal; Head and Neck Neoplasms; Human | 2023 |
Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Epithelial-Mesenchymal T | 2016 |
Inhibition of the adhesion of E. coli on cultured human epithelial cells in the presence of promethazine or imipramine.
Topics: Adhesiveness; Carcinoma, Squamous Cell; Cell Division; Cell Line; Epithelium; Escherichia coli; Fimb | 1983 |
Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains.
Topics: Adenylyl Cyclases; Biological Transport; Carcinoma, Squamous Cell; Cell Membrane; Chlorpromazine; Ch | 1998 |
Alterations of beta-adrenergic, muscarinic cholinergic receptors and imipramine binding sites in human lung tumors.
Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Carcinoma, Squamous Cell; Humans; Imipramine; In Vitro | 1987 |